Press Releases

News

Governor Cuomo Announces First-Ever Biotech Venture Between U.S. and Cuba to Research and Develop New Cancer Treatments

Governor Andrew M. Cuomo today announced Buffalo-based Roswell Park Comprehensive Cancer Center has formed Innovative Immunotherapy Alliance S.A., the first-ever biotech venture between the U.S. and Cuba. The announcement marks a significant milestone of progress following Governor Cuomo’s landmark trade mission to Cuba in April 2015, where he facilitated this historic partnership between Roswell Park and the Center for Molecular Immunology. This historic step will advance the research and development of new cancer medicines that may prolong and enhance survival for thousands of U.S. patients.
Dr. Marc Ernstoff
News

New Immunotherapy Approach Found in “Superagonist” Interleukin-15 Complex

A recent development shows that the immune response to cancer can be further enhanced using cytokines, small proteins that act as chemical messengers transporting information between different types of immune cells. A clinical trial led by Marc Ernstoff, MD, the Katherine Anne Gioia Chair of Medicine at Roswell Park Comprehensive Cancer Center, found that a drug complex containing one of these cytokines, interleukin-15 (IL-15), is both safe and well tolerated in patients with advanced solid tumors. The findings have been published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).

News

Adolescent Users of Juul, Other E-Cigarette Pods Exposed to Nearly As Much Nicotine as Smokers, Study Shows

A new study on use of electronic cigarettes among adolescents reports striking findings: that young users of newer “pod” e-cigarette devices are absorbing nicotine at levels approaching nicotine exposure from traditional combustible cigarettes. The research, a collaboration between scientists at Roswell Park Comprehensive Cancer Center and pediatricians from Stony Brook Children’s Hospital, also reveals that Juul and similar products contain high concentrations of a modified, salt form of nicotine, which is more readily absorbed upon inhalation.
Dean Tang, PhD
News

Roswell Park Team Identifies Possible Cause of Resistance to Prostate Cancer Treatment

A collaborative research team has linked the development of castration-resistant prostate cancer and resistance to treatment to a lack of androgen receptor expression in prostate cancer cells, identifying a new therapeutic target for one of the deadliest forms of cancer among men. Results of this research, which was led by scientists at Roswell Park Comprehensive Cancer Center, were published today in the journal Nature Communications.